Evidence map›Paper›PMID 28329674›Full record

ArticleCell reports2017

β-Arrestin2 Couples Metabotropic Glutamate Receptor 5 to Neuronal Protein Synthesis and Is a Potential Target to Treat Fragile X.

Laura J Stoppel, Benjamin D Auerbach, Rebecca K Senter, Anthony R Preza, Robert J Lefkowitz, Mark F Bear

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Pharmacological reviews · 2023
    Review
  12. Review
  13. Review
  14. Stabilization of Spine Synaptopodin by mGluR1 Is Required for mGluR-LTD.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2022
    Article
  15. Review
  16. Review
  17. Review
  18. De novo missense variants inJournal of medical genetics · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Laura J StoppelThe Picower Institute for Learning and Memory, Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Benjamin D AuerbachThe Center for Hearing and Deafness, Department of Communicative Disorders and Sciences, The State University of New York at Buffalo, Buffalo, NY 14214, USA.
Rebecca K SenterThe Picower Institute for Learning and Memory, Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Anthony R PrezaThe Picower Institute for Learning and Memory, Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Robert J LefkowitzDepartments of Medicine and Biochemistry, Howard Hughes Medical Institute, Duke University Medical Center, Durham, NC 27710, USA.
Mark F BearThe Picower Institute for Learning and Memory, Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. Electronic address: mbear@mit.edu.
Massachusetts Institute of Technology · USDuke Medical Center · USUniversity at Buffalo, State University of New York · US

Funding

Molecular Regulation of Cardiovascular 7 TM ReceptorsR01HL016037 · NHLBI · DUKE UNIVERSITY · PI ROBERT J LEFKOWITZ · 1985 to 2026
$14.5M
Behavioral Consequences and cellular substrates of plasticity in visual cortexR01EY023037 · NEI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI BEAR, MARK F · 2013 to 2025
$6.0M
Mechanisms and Functions of FMRP in Neuronal DevelopmentR01HD046943 · NICHD · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI BEAR, MARK F · 2003 to 2014
$2.9M
Synaptic pathophysiology of the 16p11.2 microdeletion mouse modelR01MH106469 · NIMH · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI BEAR, MARK F · 2015 to 2019
$2.7M
Training Program in the Neurobiology of Learning and MemoryT32MH074249 · NIMH · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI BEAR, MARK F · 2007 to 2016
$1.7M
Validating a novel target for correction of pathophysiology in fragile X and TSCR21NS087225 · NINDS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI BEAR, MARK F · 2014 to 2015
$404k
NEI NIH HHS R01 EY023037NHLBI NIH HHS R01 HL016037NICHD NIH HHS R01 HD046943NIMH NIH HHS R01 MH106469NIMH NIH HHS T32 MH074249NINDS NIH HHS R21 NS087225
6 · The paper itself

Abstract

Synaptic protein synthesis is essential for modification of the brain by experience and is aberrant in several genetically defined disorders, notably fragile X (FX), a heritable cause of autism and intellectual disability. Neural activity directs local protein synthesis via activation of metabotropic glutamate receptor 5 (mGlu

Indexed as

Molecular Targeted TherapyProtein BiosynthesisAnimalsBehavior, Animalbeta-Arrestin 2Disease Models, AnimalDizocilpine MaleateExtracellular Signal-Regulated MAP KinasesFemaleFragile X Messenger Ribonucleoprotein 1Fragile X SyndromeGene DeletionGTP-Binding Protein alpha Subunits, Gq-G11HeterozygoteHippocampusLocomotionbeta-Arrestin 2Dizocilpine MaleateExtracellular Signal-Regulated MAP KinasesFragile X Messenger Ribonucleoprotein 1GTP-Binding Protein alpha Subunits, Gq-G11Receptor, Metabotropic Glutamate 5autismbiased ligandsERKfragile Xintellectual disabilitylong-term depressionmetabotropic glutamate receptorsmGluR5synaptic protein synthesisβ-arrestin2

Identifiers

PMID28329674
PMCPMC5391046
OpenAlexW2597685695

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.